top of page
Systemic Therapeutics Uncovers the Protective Mechanism of Caffeine Against Cardiovascular Disease
Scientists from Systemic Therapeutics Corp. have a new understanding of the protective effects of caffeine on the cardiovascular system.
Feb 9, 2022
Scientists Discover How Caffeine Protects Against Cardiovascular Disease
Scientists have a new understanding of the protective effects of caffeine on the cardiovascular system.
Feb 9, 2022
Systemic Therapeutics Uncovers the Protective Mechanism of Caffeine Against Cardiovascular Disease
Scientists from Systemic Therapeutics Corp. have a new understanding of the protective effects of caffeine on the cardiovascular system.
Feb 9, 2022
Caffeine blocks SREBP2-induced hepatic PCSK9 expression
Evidence suggests that caffeine (CF) reduces cardiovascular disease (CVD) risk.
Feb 9, 2022
Systemic Therapeutics Announces the Appointment of Its Executive Team
Systemic Therapeutics Corp. (the "Company" or "SystemicTx") is a pre-clinical stage, biotechnology company.
Jan 31, 2022
Variant increases ER chaperones GRP78 and GRP94 and protects against liver injury
We have uncovered a cochaperone function for PCSK9Q152H that explains its hepatoprotective effects.
Nov 19, 2020
bottom of page